Massachusetts Finalizes Regulations and Code of Conduct for Medical Device and Pharmaceutical Relationships with Health Care Practitioners
Client Alert | 1 min read | 03.13.09
This week, Massachusetts approved regulations creating a new state-authored marketing code of conduct for interactions between health care practitioners and pharmaceutical and medical device manufacturers. The regulations are effective on July 1, 2009.
The regulations require manufacturers to designate a compliance officer and establish compliance and training programs. The regulations also require manufacturers to adopt a code of conduct, which incorporates voluntary industry codes adopted by the Pharmaceutical Research and Manufacturers of America and the Advanced Medical Technology Association. Notably, the state-mandated code of conduct incorporates requirements in addition to these two voluntary industry codes and explicitly restricts a broad variety of conduct, including a ban on providing items such as pens and mugs.
The subject of much debate among stakeholders, the new regulations also establish reporting requirements for certain payments made to "covered recipients," including mandating that manufacturers report certain payments exceeding a $50 threshold made to healthcare practitioners, hospitals, nursing homes, pharmacists and health benefit plan administrators. The $50 limit is not cumulative but calculated on an individual transactional basis. The law does provide for several disclosure exemptions, such as certain payments made in conjunction with research and clinical trials, demonstration or evaluation units, and rebates and discounts; however, several categories of indirect payments are not exempt, including charitable donations to universities or hospitals, sponsorship of continuing medical education, and third-party professional or scientific meetings or conferences. The first disclosure reports are due on July 1, 2010.
Insights
Client Alert | 3 min read | 09.15.25
On August 19, 2025, the U.S. Senate Committee on Finance (“Senate Finance Committee”) sent Paul Atkins, Chairman, U.S. Securities and Exchange Commission (“SEC”) a letter calling on the SEC to investigate White River Energy Corp (“White River”). In the letter, the Senate Finance Committee confirmed a criminal investigation into White River related to the sale of so-called “tribal tax credits” that according to both Congress and the IRS, do not exist. The letter further states that White River allegedly earned millions of dollars selling these credits and has not been forthcoming with investors regarding the existence of the criminal investigation. According to the Senate Finance Committee, White River has failed to file financial disclosure documents with the SEC since March 15, 2024, missing six consecutive reporting periods. The letter instructs White River to disclose the existence of the DOJ criminal tax investigation, and calls on the SEC to take action if White River fails to do so.
Client Alert | 4 min read | 09.12.25
SBA’s OHA Further Defines Extraordinary Action in SDVOSB Appeal
Client Alert | 6 min read | 09.11.25
U.S. Department of Commerce Partially Relaxes Export Controls on Syria
Client Alert | 9 min read | 09.11.25
